The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes
Lana Bridi(University of California San Diego), Veeral Ajmera(University of California San Diego), Saaket Agrawal(Massachusetts General Hospital), Rohit Loomba(University of California San Diego), Kaleb Tesfai(University of California San Diego), Ricki Bettencourt(University of California San Diego), Egbert Madamba(University of California San Diego), Lisa Richards(University of California San Diego), Amit V. Khera(Broad Institute)
Cited by 21
Related Papers
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
|Nature Genetics|2018|3.1k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k